BCL2 and colonic neoplasm: Glabridin inhibits cancer cell proliferation by downregulating PI3K, AKT, and mTOR, upregulating Bax, caspase-3, and caspase-9, and reducing Bcl-2, inducing colon cancer cell death through the intrinsic apoptosis pathway.